208 related articles for article (PubMed ID: 9151803)
1. A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo.
Engleman VW; Nickols GA; Ross FP; Horton MA; Griggs DW; Settle SL; Ruminski PG; Teitelbaum SL
J Clin Invest; 1997 May; 99(9):2284-92. PubMed ID: 9151803
[TBL] [Abstract][Full Text] [Related]
2. Design and characterization of orally active Arg-Gly-Asp peptidomimetic vitronectin receptor antagonist SB 265123 for prevention of bone loss in osteoporosis.
Lark MW; Stroup GB; Hwang SM; James IE; Rieman DJ; Drake FH; Bradbeer JN; Mathur A; Erhard KF; Newlander KA; Ross ST; Salyers KL; Smith BR; Miller WH; Huffman WF; Gowen M
J Pharmacol Exp Ther; 1999 Nov; 291(2):612-7. PubMed ID: 10525079
[TBL] [Abstract][Full Text] [Related]
3. Antagonism of the osteoclast vitronectin receptor with an orally active nonpeptide inhibitor prevents cancellous bone loss in the ovariectomized rat.
Lark MW; Stroup GB; Dodds RA; Kapadia R; Hoffman SJ; Hwang SM; James IE; Lechowska B; Liang X; Rieman DJ; Salyers KL; Ward K; Smith BR; Miller WH; Huffman WF; Gowen M
J Bone Miner Res; 2001 Feb; 16(2):319-27. PubMed ID: 11204432
[TBL] [Abstract][Full Text] [Related]
4. The integrin ligand echistatin prevents bone loss in ovariectomized mice and rats.
Yamamoto M; Fisher JE; Gentile M; Seedor JG; Leu CT; Rodan SB; Rodan GA
Endocrinology; 1998 Mar; 139(3):1411-9. PubMed ID: 9492078
[TBL] [Abstract][Full Text] [Related]
5. Blockade of osteoclast-mediated bone resorption through occupancy of the integrin receptor: a potential approach to the therapy of osteoporosis.
Dresner-Pollak R; Rosenblatt M
J Cell Biochem; 1994 Nov; 56(3):323-30. PubMed ID: 7876325
[TBL] [Abstract][Full Text] [Related]
6. Contortrostatin, a homodimeric snake venom disintegrin, is a potent inhibitor of osteoclast attachment.
Mercer B; Markland F; Minkin C
J Bone Miner Res; 1998 Mar; 13(3):409-14. PubMed ID: 9525341
[TBL] [Abstract][Full Text] [Related]
7. Integrins and osteoclastic resorption in three bone organ cultures: differential sensitivity to synthetic Arg-Gly-Asp peptides during osteoclast formation.
van der Pluijm G; Mouthaan H; Baas C; de Groot H; Papapoulos S; Löwik C
J Bone Miner Res; 1994 Jul; 9(7):1021-8. PubMed ID: 7942148
[TBL] [Abstract][Full Text] [Related]
8. Peptidomimetic antagonists of alphavbeta3 inhibit bone resorption by inhibiting osteoclast bone resorptive activity, not osteoclast adhesion to bone.
Carron CP; Meyer DM; Engleman VW; Rico JG; Ruminski PG; Ornberg RL; Westlin WF; Nickols GA
J Endocrinol; 2000 Jun; 165(3):587-98. PubMed ID: 10828842
[TBL] [Abstract][Full Text] [Related]
9. Arg-Gly-Asp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts.
Horton MA; Taylor ML; Arnett TR; Helfrich MH
Exp Cell Res; 1991 Aug; 195(2):368-75. PubMed ID: 1712731
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of osteoclastic bone resorption in vivo by echistatin, an "arginyl-glycyl-aspartyl" (RGD)-containing protein.
Fisher JE; Caulfield MP; Sato M; Quartuccio HA; Gould RJ; Garsky VM; Rodan GA; Rosenblatt M
Endocrinology; 1993 Mar; 132(3):1411-3. PubMed ID: 8440195
[TBL] [Abstract][Full Text] [Related]
11. Bone sialoprotein supports breast cancer cell adhesion proliferation and migration through differential usage of the alpha(v)beta3 and alpha(v)beta5 integrins.
Sung V; Stubbs JT; Fisher L; Aaron AD; Thompson EW
J Cell Physiol; 1998 Sep; 176(3):482-94. PubMed ID: 9699501
[TBL] [Abstract][Full Text] [Related]
12. Role of alpha(v)beta(3) integrin in osteoclast migration and formation of the sealing zone.
Nakamura I; Pilkington MF; Lakkakorpi PT; Lipfert L; Sims SM; Dixon SJ; Rodan GA; Duong LT
J Cell Sci; 1999 Nov; 112 ( Pt 22)():3985-93. PubMed ID: 10547359
[TBL] [Abstract][Full Text] [Related]
13. A peptidomimetic antagonist of the integrin alpha(v)beta3 inhibits Leydig cell tumor growth and the development of hypercalcemia of malignancy.
Carron CP; Meyer DM; Pegg JA; Engleman VW; Nickols MA; Settle SL; Westlin WF; Ruminski PG; Nickols GA
Cancer Res; 1998 May; 58(9):1930-5. PubMed ID: 9581835
[TBL] [Abstract][Full Text] [Related]
14. Effects of kistrin on bone resorption in vitro and serum calcium in vivo.
King KL; D'Anza JJ; Bodary S; Pitti R; Siegel M; Lazarus RA; Dennis MS; Hammonds RG; Kukreja SC
J Bone Miner Res; 1994 Mar; 9(3):381-7. PubMed ID: 8191932
[TBL] [Abstract][Full Text] [Related]
15. Biological and molecular properties of a new alpha(v)beta3/alpha(v)beta5 integrin antagonist.
Belvisi L; Riccioni T; Marcellini M; Vesci L; Chiarucci I; Efrati D; Potenza D; Scolastico C; Manzoni L; Lombardo K; Stasi MA; Orlandi A; Ciucci A; Nico B; Ribatti D; Giannini G; Presta M; Carminati P; Pisano C
Mol Cancer Ther; 2005 Nov; 4(11):1670-80. PubMed ID: 16275988
[TBL] [Abstract][Full Text] [Related]
16. Non-cytotoxic cobra cardiotoxin A5 binds to alpha(v)beta3 integrin and inhibits bone resorption. Identification of cardiotoxins as non-RGD integrin-binding proteins of the Ly-6 family.
Wu PL; Lee SC; Chuang CC; Mori S; Akakura N; Wu WG; Takada Y
J Biol Chem; 2006 Mar; 281(12):7937-45. PubMed ID: 16407244
[TBL] [Abstract][Full Text] [Related]
17. Approach to discovering novel therapeutic agents for osteoporosis based on integrin receptor blockade.
Chorev M; Dresner-Pollak R; Eshel Y; Rosenblatt M
Biopolymers; 1995; 37(6):367-75. PubMed ID: 8589242
[TBL] [Abstract][Full Text] [Related]
18. Synthetic peptide containing Arg-Gly-Asp inhibits bone formation and resorption in a mineralizing organ culture system of fetal rat parietal bones.
Gronowicz GA; Derome ME
J Bone Miner Res; 1994 Feb; 9(2):193-201. PubMed ID: 8140932
[TBL] [Abstract][Full Text] [Related]
19. Modulation of vitronectin receptor-mediated osteoclast adhesion by Arg-Gly-Asp peptide analogs: a structure-function analysis.
Horton MA; Dorey EL; Nesbitt SA; Samanen J; Ali FE; Stadel JM; Nichols A; Greig R; Helfrich MH
J Bone Miner Res; 1993 Feb; 8(2):239-47. PubMed ID: 7680185
[TBL] [Abstract][Full Text] [Related]
20. Integrin receptor-mediated mobilisation of intranuclear calcium in rat osteoclasts.
Shankar G; Davison I; Helfrich MH; Mason WT; Horton MA
J Cell Sci; 1993 May; 105 ( Pt 1)():61-8. PubMed ID: 7689577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
